All In Biotech

Drug Trial Radar · NCT02386592

Prevention of Nosocomial Bacteremia Among Zambian Neonates

Prevention of Nosocomial Bacteremia and Mortality Among Neonates at a Tertiary Referral Center in Zambia

Last checked: Nov 19, 2026Latest source record: Jul 31, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

9,410

Actual

Start

Sep 1, 2015

Primary completion

Apr 15, 2017

Study completion Jul 2017

Sponsor

Lead sponsor
Boston UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University Teaching Hospital, Lusaka, Zambia; Zambia Center for Applied Health Research and Development; Children's Hospital of Philadelphia
First posted
Mar 12, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 1 hour, up to 28 days
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to estimate the burden of disease, identify risk factors associated with nosocomial bacteremia among neonates and assess the efficacy of low-cost measures targeted to known and suspected nosocomial BSI (bloodstream) risk factors, the investigators propose to study the impact of a novel package of infection control interventions on nosocomial bacteremia and mortality among neonates at a tertiary care center in sub-Saharan Africa.

Conditions

  • Neonatal Sepsis
  • Neonatal Mortality

Interventions

  • Chlorhexidine gluconate (CHG)Drug

    All enrolled neonates admitted to the NICU during the implementation and intervention periods will undergo CHG bathing (sparing head and face) at the time of admission at and thereafter once weekly.

  • Hand hygiene (HH)Behavioral

    Alcohol hand rub will be produced in the hospital pharmacy and will be readily available in the NICU (via wall-mounted dispensers) throughout the intervention period. Hand hygiene among NICU physicians and nurses will actively be promoted through the intervention period.

  • Infection control trainingBehavioral

    All NICU healthcare workers will receive infection prevention training which will involve structure training on HH, universal precautions, neonatal skin antisepsis and peripheral IV placement and line care.

  • Infection control reminders via SMS textOther

    Infection control practice reminders will be sent to NICU healthcare workers on a daily basis via SMS messages.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause neonatal mortality in hospitalized neonatesTime frame: 18 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Teaching Hospital

    Lusaka, Zambia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.